11
Tuesday
December 2018
5:19 PM IST
News Headlines
Home   | Main News   | Kerala  | National   | International  | Business   | Sports   | Entertainment   | Columns   | Offbeat   | Health   | About Deepika 
Business News
Sun Pharma expects normalisation of India biz in FY'19
 
New Delhi, Oct 2 (PTI) Sun Pharma expects its India business to stabilise in the current fiscal leading to "reasonable volume growth" after witnessing disruptions in 2017-18 due to GST implementation, a top company official said.

In a message to shareholders in the company's Annual Report for 2017-18, Sun Pharma Managing Director Dilip Shanghvi however said the government's enforced price cuts and policy changes are potential risk factors for the business.

"We expect normalisation of the India business in 2018-19 post the disruption in 2017-18 due to GST implementation. Favourable demographics will ensure reasonable volume growth in India," Shanghvi said.

However, government-mandated price reductions/policy changes continue to be potential risks for this business, he added.

The company's India business revenues stood at Rs 8,029 crore in 2017-18, a growth of 4 per cent over 2016-17.

Shanghvi said the short-term outlook for the US generics market continues to be challenging given the pricing pressures.

"We are also expecting reasonable growth in our emerging markets business, however, as always, currency fluctuations continue to be a risk," he added.

Elaborating further, he said the company is in the process of gradually ramping up its global specialty business.

"We plan to increase its contribution to our consolidated revenues in the long term. This will entail significant front-ended investments, with commensurate revenue streams accruing only over a period of time," Shanghvi said.

Some of the company's specialty products are likely to be commercialised in the US in 2018-19 and hence it expects to incur significant pre-launch and branding costs along with increasing sales force costs, he added.

"Given these factors, we expect a low double-digit topline growth in our consolidated revenues for 2018-19 over 2017-18," Shanghvi said.

The Mumbai-based drug firm posted consolidated revenues of Rs 26,489.46 crore for 2017-18.

Shanghvi said the company's consolidated R&D investments for 2018-19 will be about 8-9 per cent of its revenues.


Sensex cracks over 550 pts; Nifty drops below 10,600
India's coal output up 10% to 156 MT during Apr-Nov
Prabhu links creativity & business opportunities to cheap beverages in Goa
31st GST Council to meet on Dec 22 in Delhi
Cabinet Approves Policy to Double Farm Exports to $60 Billion by 2022
RBI keeps key rates unchanged
NTPC wins 85 MW solar capacity in UP Govt tender
Maintain status on currency management, HC tells SBI
Amway India enters herbal skincare space
New 2018 Maruti Suzuki Ertiga Launched In India, Prices Start At ? 7.44 lakh
Centre's New Move May Escalate Feud With RBI Ahead Of Board Meet: Report
Air India eyes Rs 800 cr from sale of over 70 properties
Intel India opens design house costing Rs 1,100 cr at B'luru
Sensex rebounds 332 pts on easing crude, rupee gains
Govt mulls second round of 2,500 MW medium-term PPA auction
India invites Swedish companies to explore investment opportunities
Govt cancels ED officer Rajeshwar Singh's leave
Facebook blocks 115 accounts ahead of US midterm elections
Indian norms on PCA, capital are conservative, rule-based: SBI
SBI back in black on credit growth
KERALA NEWS
Activist Rehana Fathima, Who Attempted Sabarimala Trek, Arrested Over Facebook Post
 (Kochi, Nov 28, 2018): Model and activist Rehana Fathima, who tried to reach Kerala's Sabarim  
Good news for Keralite Nurses: IELTS cut-off reduced to 6.5
BJP leader K Surendran, 71 others granted bail
Sabarimala protests: Arrests up to 2061, Kerala HC warns police
INTERNATIONAL NEWS
Trump's potential next chief of staff pick leaving White House
 Washington, Dec 10 (AFP) The White House official widely touted as Donald Trump's favourite to succe
UK PM faces fight for her political life in Brexit deal
Iran arrests 10 over suicide attack on police
Trump chooses new Joint Chiefs of Staff chairman, against Mattis wishes
NATIONAL NEWS
BJP mocks Oppn meet, asks them to reveal PM candidate's name
 Kolkata, Dec 10 (PTI) BJP national general secretary Kailash Vijayvargiya has mocked the scheduled m
RBI Governor Urjit Patel makes loud noise with silent exit
Can special consideration be shown to man with skin disorder: HC asks Centre
BJP files caveat in SC over 'rath yatra' in WB
Untitled Page
Rashtra Deepika LTD
Copyright @ 2018 , Rashtra Deepika Ltd.